Article
Envision Pharma Group
How Will AI and Machine Learning Affect the MSL
Summary
In this episode, Tom Caravela is joined by Dr. Sanjay Singhvi to delve into the transformative role of AI in medical affairs. They discuss AI's ability to address industry challenges, its practical applications for MSLs, and its impact on decision-making processes. The conversation extends to AI's utility for managers in trend analysis and resource allocation. They also explore how AI can benefit job seekers and entry-level MSLs, particularly in resume optimization and interview preparation. The episode wraps up with insights into current industry trends and a reflection on AI's limitations, concluding with sponsor acknowledgments and closing remarks.
Dr Sanjay Singhvi, Director at VMLY&R Health discusses how artificial intelligence and machine learning will affect the role of the MSL.
This episode is sponsored by the Digital Solutions division at VMLY&R Health. **VMLY&R Health is a global agency united around a single purpose: improving health all over the world by making science meaningful. For more details about their innovative technology solutions designed specifically for Medical Affairs, please visit https://www.vmlyr.com/health/digitalsolutions
AI in Medical Affairs, Transformative Role of AI, AI for MSLs, AI in Healthcare, AI and Job Seekers
Related Topics
You May Also Like
Envision Pharma Group
Press Release
Joe Pardavila sits down with Dr. Ramin Farhood and Dr. Kirk Shepard
Breaking Silos in Oncology Dr Ramin Farhood & Dr Kirk Shepard on Voices of Oncology
Podcast
MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper
The Struggle With KOL Access in Todays World
Podcast
MSL Talk: Tom Caravela, Paul Ward
How Medical Affairs Professionals Should Engage with Digital Opinion Leaders
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD